US Patent 8628768 Therapeutic ribonucleases
Patent 8628768 was granted and assigned to Quintessence Biosciences on January, 2014 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 10, 2012
Date of Patent
January 14, 2014
Patent Application Number
13545387
Patent Inventor Names
Laura Strong
0
Tony Klink
0
John Kink
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8628768 Therapeutic ribonucleases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.